buprenorphine
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
28 FDA-registered drug labelers
Alvogen Inc.
Amneal Pharmaceuticals NY LLC
Arevipharma GmbH
Aveva Drug Delivery Systems Inc.
Braeburn Inc.
Bryant Ranch Prepack
Indivior Inc.
Indivior UK Limited
INGENUS PHARMACEUTICALS, LLC
Janssen Pharmaceutica NV
Janssen Pharmaceutical Sciences Unlimited Company
Lannett Company, Inc.
LTS Therapy Systems, LLC
Macfarlan Smith Limited
Medisca Inc
Noramco, LLC
PCAS
Purdue Pharma LP
Rhodes Pharmaceuticals L.P.
Siegfried AG
Siegfried PharmaChemikalien Minden Gmbh
Siegfried USA, LLC
SpecGx LLC
SUN PHARMACEUTICAL INDUSTRIES, INC.
TAPI Czech Industries s.r.o.
Teva Czech Industries s.r.o
Teva Pharmaceuticals USA, Inc.
Veranova, L.P.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 6 drug and cosmetic product listings (FDA).
- •Sublocade
- •Buprenorphine
- •Butrans
- •buprenorphine transdermal system
- •Brixadi
- •Buprenorphine and Naloxone
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS52485-79-7
PubChem CID644073
DTXSIDDTXSID2022705
FormulaC29H41NO4
Mol. Weight467.6 g/mol
SMILESCC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O
Data Sources
6440732026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/buprenorphine/cids/JSON
Archive: data/sources/pubchem_name/buprenorphine.json
CAS 52485-79-72026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
bulk match2026-04-07
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json